Effects of zidovudine: A Synthesis of Findings from 5 Studies

  1. Home
  2. Effects of zidovudine
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician.Data sources and disclaimers (data limitations, copyright, etc.)The analysis on "Effects of zidovudine: A Synthesis of Findings from 5 Studies" on this page is based on PubMed data provided by the U.S. National Library of Medicine (NLM). However, NLM does not endorse or verify these analyses.

This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.

This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of zidovudine: A Synthesis of Findings from 5 Studies", please consult your doctor.

For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
This page's analysis is based on PubMed data provided by the U.S. National Library of Medicine (NLM).
Original Abstract of the Article

Major Research Findings

Zidovudine is an antiretroviral drug used to treat HIV infection. Several studies have revealed the effects and side effects of zidovudine. 2 found that 96% of HIV-positive men who received zidovudine experienced side effects, the most common being nausea (64%), fatigue (55%), and headache (49%). These side effects were generally self-limited and reappeared briefly with each dose increase. A decrease in hemoglobin levels occurred shortly after the start of therapy. This was not dose-dependent and reversed quickly upon discontinuation of treatment. 3 found that nearly all patients experienced an increase in MCV and a decrease in neutrophil count during treatment with zidovudine. Additionally, zidovudine has been suggested to delay the progression of HIV infection. 1 found that zidovudine delayed progression to AIDS or ARC in patients with asymptomatic or mildly symptomatic HIV infection. The study also revealed that zidovudine prolonged survival in patients with more severe infection. 5 evaluated the long-term effects of zidovudine exposure on uninfected children born to HIV-infected mothers. The study found no significant differences between zidovudine-exposed and placebo-exposed children in terms of lymphocyte subsets, weight, height, head circumference, and cognitive/developmental function. No deaths or malignancies were observed. These studies suggest that zidovudine is an effective drug for treating HIV infection. However, zidovudine can cause side effects, and dosage may need to be adjusted.

Benefits and Risks

Benefits Summary

Zidovudine is an effective drug for treating HIV infection. Zidovudine delays the progression of HIV infection and prolongs the survival of patients with more severe infection. 1 Also, zidovudine has been shown to have no long-term side effects on HIV-negative children born to HIV-infected mothers. 5

Risks Summary

Zidovudine can cause side effects such as nausea, fatigue, and headache. 2 It can also cause hematologic side effects such as a decrease in hemoglobin levels, an increase in mean corpuscular volume (MCV), and a decrease in neutrophil count. 3 These side effects are generally mild and reappear temporarily with each dose increase. However, severe side effects can occur, and treatment may need to be discontinued.

Comparison Across Studies

Commonalities

All four studies investigated the effects and side effects of zidovudine. These studies suggest that zidovudine is an effective drug for treating HIV infection, but they also reveal that it can cause side effects.

Differences

The studies differ in terms of their subjects, dosages, and evaluation methods. 2 was a multicenter prospective study involving HIV-positive men. This study evaluated the effects and side effects of zidovudine at three different doses: 600 mg/day, 900 mg/day, and 1200 mg/day. 3 was a study of 138 patients in Denmark. This study investigated the therapeutic effects and side effects of zidovudine. 1 was a review article that reviewed the literature on the effects and side effects of zidovudine. 5 was a prospective cohort study of HIV-negative children born to HIV-infected mothers. This study compared the long-term effects of zidovudine exposure with placebo exposure.

Consistency and Discrepancies

These studies suggest that zidovudine is an effective drug for treating HIV infection. However, they also reveal that zidovudine can cause side effects. There may be slight variations in the incidence and types of side effects across studies. This is likely due to differences in study subjects, dosages, and evaluation methods.

Implications for Everyday Life

Zidovudine is an effective drug for treating HIV infection, but it's important to remember that it can cause side effects. If you are taking zidovudine, consult with your doctor to understand the risks and benefits of the medication. The dosage of zidovudine varies depending on the individual patient. Your doctor will determine the appropriate dosage based on your condition. Zidovudine can also interact with other medications. Therefore, you should inform your doctor if you are taking other medications. If you are taking zidovudine, you should have regular blood tests. This is because zidovudine can affect blood cells.

Limitations of Current Research

These studies provide valuable information about the effects and side effects of zidovudine, but they have some limitations. For example, these studies were conducted on specific populations of patients, so the same results may not be obtained in other populations. Additionally, these studies were conducted over a relatively short period of time, so the long-term effects of zidovudine are not yet fully understood.

Future Research Directions

Further research on the effects and side effects of zidovudine is needed. In particular, further research is needed on the long-term effects of zidovudine, the effects in different populations of patients, and interactions with other medications. Research on ways to reduce the side effects of zidovudine should also be pursued.

Conclusion

Zidovudine is an effective drug for treating HIV infection. However, zidovudine can cause side effects. If you are taking zidovudine, consult with your doctor to understand the risks and benefits of the medication. Also, further research on the long-term effects of zidovudine is needed. Zidovudine is an important tool in the fight against HIV infection. However, when taking zidovudine, it is essential to work with your doctor to minimize the risk of side effects and maximize treatment effectiveness.

Literature analysis of 5 papers
Positive Content
4
Neutral Content
0
Negative Content
1
Article Type
5
0
0
1
5
1.

Zidovudine (Retrovir) update.

Author: RachlisA R

Delayed disease progression
Prolonged survival
Toxic effects
Zidovudine resistance

This review examines the use of zidovudine (AZT) for treating HIV infection. While AZT has been shown to improve survival in patients with AIDS or advanced HIV infection, its effectiveness in earlier stages is less clear. Lower doses of AZT were associated with fewer side effects. AZT has been shown to delay disease progression in patients with early HIV infection and low CD4 counts. While the development of drug resistance has been observed, it is not yet clear how this affects clinical outcomes. The optimal time to start AZT treatment in asymptomatic patients with low CD4 counts remains uncertain. Further research is needed to better understand when to start treatment, how to manage side effects, and the potential for combination therapies.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
GuidelineRecommendations and best practices developed by experts for healthcare professionals to refer to when making clinical judgments and providing care.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.

Language : English

2.

Nature, time course and dose dependence of zidovudine-related side effects: results from the Multicenter Canadian Azidothymidine Trial.

Author: GelmonK, MontanerJ S, FanningM, SmithJ R, FalutzJ, TsoukasC, GillJ, WellsG, O'ShaughnessyM, WainbergM

Bone marrow changes
Hemoglobin decrease
Zidovudine side effects

Zidovudine treatment resulted in dose-dependent side effects, including nausea, fatigue, and headache, with a decrease in hemoglobin and bone marrow changes.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

3.

Zidovudine treatment of AIDS and ARC in Denmark 1987.

Author: TeglbjaergL L, MathiesenL R, SøebergB, NielsenL, ThorsenB, BuhlM, PedersenC, BonnevieO, NielsenC, VestergaardB F

Increased CD4+ cells
Reduced mortality
Decreased neutrophil count
Increased MCV
Opportunistic infections

Zidovudine treatment in 138 patients with AIDS and ARC showed a significantly lower mortality rate compared to historical controls. The treatment was generally well-tolerated, with manageable side effects.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Language : English

4.

Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.

Author: LenderkingW R, GelberR D, CottonD J, ColeB F, GoldhirschA, VolberdingP A, TestaM A

Delay disease progression
Adverse events

This paper discusses the need to consider the quality of life associated with zidovudine therapy for asymptomatic HIV-infected patients. The effects of adverse events and the benefits of delayed disease progression should be weighed to optimize treatment decisions.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
Research Support, U.S. Gov't, P.H.S.Research funding provided by the Public Health Service (PHS).

Language : English

5.

Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.

Author: CulnaneM, FowlerM, LeeS S, McSherryG, BradyM, O'DonnellK, MofensonL, GortmakerS L, ShapiroD E, ScottG, JimenezE, MooreE C, DiazC, FlynnP M, CunninghamB, OleskeJ

Cardiomyopathy

No adverse effects were observed in HIV-uninfected children with in utero and neonatal exposure to zidovudine followed up for as long as 5.6 years. In a prospective cohort study of 234 uninfected children born to 230 HIV-infected women, there were no significant differences between children exposed to zidovudine and those who received placebo in terms of lymphocyte subsets, weight, height, head circumference z scores, and cognitive/developmental function.

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Multicenter StudyResearch conducted in collaboration with multiple research institutions. It aims to collect a wide range of data and obtain more generalizable results.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Language : English

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.